These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13887715)

  • 1. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 2. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 4. [EFFECT OF ALPHA-METHYLDOPALANINE AND SERYLTRIHYDROXYBENZYLHYDRAZINE (RO 4-4602) ON THE DOPA-DECARBOXYLASE ACTIVITY].
    CHRUSCIEL TL; POJDA SM
    Acta Physiol Pol; 1965; 16():111-5. PubMed ID: 14338596
    [No Abstract]   [Full Text] [Related]  

  • 5. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
    SCHAER H; ZIEGLER WH
    Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633
    [No Abstract]   [Full Text] [Related]  

  • 7. MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA.
    MORAN JF; SOURKES TL
    J Pharmacol Exp Ther; 1965 May; 148():252-61. PubMed ID: 14301016
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.
    Bartholini G; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):323-4. PubMed ID: 4390126
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON THE STEREOSPECIFICITY OF THE DECARBOXYLASE INHIBITING ACTION OF ALPHA-METHYLDOPA].
    PUETTER J; KRONEBERG G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Nov; 249():470-8. PubMed ID: 14335181
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACTION OF ALPHA-METHYL-HYDRAZINO-DOPA AND OF ITS PHOSPHO-5'-PYRIDOXAL HYDRAZINE ON AMINO ACID DECARBOXYLASES].
    GONNARD P; DUHAULT J; FENARD S
    J Neurochem; 1964 Nov; 11():819-24. PubMed ID: 14242333
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECT OF THE DOPA-DECARBOXYLASE INHIBITOR ALPHA-METHYLDOPA ON THE INCORPORATION OF DOPA INTO MELANIN AND PYROCATECHOLAMINE. IN VIVO STUDIES ON MELANOMA MICE WITH TRITIATED DOPA].
    HEMPEL K; DEIMEL M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1963 Nov; 246():203-14. PubMed ID: 14095447
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopa metabolism in relation to the therapy of Parkinson's syndrome].
    Pletscher A; Bartholini G
    Actual Pharmacol (Paris); 1971; 24():27-49. PubMed ID: 5150621
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 20. [DECARBOXYLASE INHIBITORS IN THE THERAPY OF ARTERIAL HYPERTENSION (L-ALPHA-METHYLDOPA)].
    BUONINCONTI R; JACONO A; VITALE P
    Minerva Med; 1963 Oct; 54():3169-74. PubMed ID: 14104505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.